MRD / Regn No. : 20230000567 Date : 20/07/2026
Patient Name : Anitha Irudayaraj Age & Gender : 45 Yrs. / Female
Contact No. : 9042988583 UHID :
Ht / Wt / BMI : 155.1 / 95 / 39.49 BP S / BP D : 128 / 84
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DM (01/Feb/2023) | OBESITY (25/May/2013) | DYSLIPIDEMIA (02/Jun/2023) | A2G1 DKD (02/Jun/2023) | VITAMIN DEFICIENCY (02/Jun/2023) | LOSS OF PROTECTIVE SENSATION (02/Jun/2023) |
Subjective : NO ABDOMINAL DISCOMFORT,FATIGUE,MILD ABDOMINAL DISCOMFORT,UNABLE TO TOLERATE 10 MG OF TIRZEPATIDE,LACRIMAL GLAND
Objective : NONE
Analysis : TYPE 2 DM,OBESITY,A2G1 DKD,DYSLIPIDEMIA,VITAMIN D DEFICIENCY,LOSS OF PROTECTIVE SENSATION
Plan : CONTINUE CURRENT MEDICATIONS,INCREASE TIRZEPATIDE TO 10 MG  
S# Generic (Trade) Name Route Dosage Usage Duration
1 ROSUVASTATIN 10 MG
ROSEDAY 10 MG
Medicine For CHOLESTEROL
PO 0-0-1 AT BEDTIME
TILL NEXT VISIT
MAY CAUSE FATIGUE AND MUSCLE PAIN
2 TELMISARTAN 40 MG
ERITEL 40 MG
Medicine For HYPERTENSION KIDNEY PROTECTION
PO 0-0-1 AT BEDTIME
TILL NEXT VISIT
MAY CAUSE HIGH POTASSIUM
3 CHOLECALCIFEROL 2000 IU
D RISE 2000 IU
Medicine For VITAMIN D
PO 0-0-1 AFTER FOOD
TILL NEXT VISIT
TAKE AT BEDTIME
4 INJECTION DEGLUDEC / ASPART (INJ U100) 70/30
RYZODEG
Medicine For DIABETES
SQ 0-22-0 UNITS BEFORE FOOD
TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
5 SRYUP SODIUM ALGINATE 250 MG
ALGIDUO
Medicine For REFLUX
PO AS DIRECTED AT BEDTIME
6 INJECTION TIRZEPATIDE 10 MG
MOUNJARO
Medicine For OBESITY
SQ ONCE A WEEK AS DIRECTED NO RELATION TO FOOD
TILL NEXT VISIT
MAY CAUSE NAUSEA CONSTIPATION OR DIARRHEA
       
Refill : 0 / Substitution:    
Education : RARE VERY RARE INSTANCES OF EYE DISTURBANCE WITH SEMAGLUTIDE HAVE BEEN REPORTED IF YOU HAVE AN EYE DISTURBANCE PLS INFORM US
Next Visit : 19/Aug/2026
Tests Suggested For Next Visit : FBS 2HPP HBA1C
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

This is a Computer generated Prescription

Powered By: